High Blood Pressure (Hypertension) Completed Phase 3 Trials for Valsartan (DB00177)

Also known as: HTN / Hypertension(HTN) / Hypertensive / Hypertension / High Blood Pressure / Blood High Pressure / Blood Pressure, High / High Blood Pressures / Blood pressure high / Essential (primary) hypertension / HT / HBP / Hypertension NOS / Hypertension arterial

IndicationStatusPhase
DBCOND0040789 (High Blood Pressure (Hypertension))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01918332Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and HyperlipidemiaTreatment
NCT00170976A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With HypertensionTreatment
NCT00170963Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan AloneTreatment
NCT00171080VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term HemodialysisTreatment
NCT00171067VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With MicroalbuminuriaTreatment
NCT00171002Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine AloneTreatment
NCT00367939Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus FelodipineTreatment
NCT00171093A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and HypercholesterolemiaTreatment
NCT00311740A Study of VAH631 in Patients With Essential Hypertension (Factorial Study)Treatment
NCT00394745Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic SyndromeTreatment
NCT00000620Action to Control Cardiovascular Risk in Diabetes (ACCORD)Prevention
NCT00171028A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 - 5 Years Who Have HypertensionTreatment
NCT00171041A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of AgeTreatment
NCT00171535Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe HypertensionTreatment
NCT00241137A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 MgTreatment
NCT00327145A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on MonotherapyTreatment
NCT003275878-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe HypertensionTreatment
NCT00338936Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study)Treatment
NCT00353912Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II HypertensionTreatment
NCT00350168Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II HypertensionTreatment
NCT00386607A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.Treatment
NCT00385931Efficacy and Safety of Valsartan and the Combination of Valsartan and SimvastatinTreatment
NCT00396656Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive PatientsTreatment
NCT00392262A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive PatientsTreatment
NCT00409643Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive PatientsTreatment
NCT00409851One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With HypertensionTreatment
NCT00413413Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With HypertensionTreatment
NCT00413049Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With HypertensionTreatment
NCT00433836Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood PressureTreatment
NCT00435162Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood PressureTreatment
NCT00446511Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With HypertensionTreatment
NCT00457626An Open Label Extension Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With HypertensionTreatment
NCT00523744Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled HypertensionTreatment
NCT00548067Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With HypertensionTreatment
NCT00591578Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential HypertensionTreatment
NCT00657241Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to LisinoprilTreatment
NCT00696436An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.Treatment
NCT00699192Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential HypertensionTreatment
NCT01365481Safety and Tolerability of Valsartan in Children 6 to 17 Years of AgeTreatment
NCT01402843Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and DyslipidemiaTreatment
NCT01415505Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 HypertensionTreatment
NCT01672476A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential HypertensionTreatment
NCT01928628Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive PatientsTreatment
NCT02177396MICARDIS® and Valsartan in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure MonitoringTreatment